NIH-funded research R01 grant

Proteins that stick to amyloid plaques in Alzheimer's

Official title: Amyloidosis associated proteins in Alzheimer’s disease pathogenesis

Funded at University of Florida · NIH-11169687 · Data updated 2026-11-12

The team is looking at whether extra proteins that collect with amyloid plaques help cause brain injury in people with Alzheimer's.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startSeptember 5, 2021
Project endAugust 31, 2026
Funding year2025
Award (this year)$739,630
NIH project number5R01AG074569-03
Project IDNIH-11169687 on NIH RePORTER

Who could benefit from this research

Could help

People with Alzheimer's disease—especially those with early-stage disease or evidence of amyloid buildup—are the group most relevant to this research.

Less likely to help

People without Alzheimer's or those with non-amyloid forms of dementia are unlikely to get direct benefit from this specific line of work.

What this research studies

This work uses detailed protein studies of human Alzheimer's brain samples and mouse models to find proteins that accumulate with amyloid-beta plaques. The researchers will combine large public proteomics datasets (like AMP-AD) with laboratory experiments in mice and molecular analyses to see which amyloid-associated proteins (AAPs) are linked to nerve-cell loss. They aim to explain why amyloid buildup can exist for years before neurodegeneration starts by testing whether AAPs help trigger the damage. The findings will guide which proteins might become targets for future tests or treatments.

Why it matters

Potential benefit: If true, this could identify new targets to stop or slow the brain damage that leads to dementia in Alzheimer's.

How similar studies have gone: Proteomics has already found many proteins in amyloid plaques, but linking specific plaque-associated proteins to downstream neurodegeneration is a relatively new and active area of research.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Prokop, Stefan — University of Florida
  • Study coordinator: Prokop, Stefan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.